
IBM (IBM) Stock Forecast & Price Target
IBM (IBM) Analyst Ratings
Bulls say
IBM demonstrates a positive financial outlook primarily driven by strong growth in its software segment, with organic revenue growth estimated at 7-8% year-over-year, and significant contributions from key products like Red Hat. The company has experienced a bullish re-rating relative to the S&P 500 due to enhanced execution, free cash flow growth, and solid performance during the mainframe product cycle, which has yielded approximately $1.8 billion in incremental hybrid infrastructure revenue over three quarters. Additionally, management's guidance for 2026 indicates revenues are expected to grow at a rate of over 5%, supported by the strategic acquisition of Confluent and a projected improvement in margins, reinforcing IBM's competitive position and financial stability.
Bears say
The analysis of IBM indicates significant financial challenges affecting the company's outlook, particularly due to heightened competition risk posed by emerging technologies like Anthropic's Claude Code, which could disrupt IBM's legacy systems business. Forecasts suggest a projected decline of approximately 1.5% in segment revenue for 2026, attributed to unfavorable foreign exchange rates and additional economic headwinds that collectively culminate in a $1.16 billion revenue reduction. Moreover, the company faces macroeconomic uncertainties, including risks tied to foreign currency fluctuations and the performance of its mainframe product cycle, which could further impact its financial stability and growth trajectory.
This aggregate rating is based on analysts' research of IBM and is not a guaranteed prediction by Public.com or investment advice.
IBM (IBM) Analyst Forecast & Price Prediction
Start investing in IBM (IBM)
Order type
Buy in
Order amount
Est. shares
0 shares